Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Xiao-Feng Powder in the Treatment of Chronic Urticaria
NCT04967092Phase 2Completed
- Start
- Aug 2021
- Primary completion
- Apr 2023
- Modality
- TCM (Traditional Chinese Medicine), Herbal Formulation
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic urticaria (CU) comparing Modified Xiao-Feng Powder with Placebo (2 arms). Primary endpoint: Urticaria Activity Score at 12 weeks. Started Aug 2021; status: completed.
02
Drugs
Modified Xiao-Feng Powder
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on NCT04967092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04967092.